Biograph & Caristo Diagnostics Announce First-Of-Its-Kind U.S. Study To Use AI To Detect Presymptomatic Cardiovascular Disease

Biograph, a preventive health and diagnostics clinic, announced a partnership with Caristo Diagnostics to become the first U.S. clinic to study a novel artificial intelligence (AI)-based preventive cardiac marker in asymptomatic patients, by detecting coronary artery inflammation from cardiac computed tomography (CT) scans. This study will be exclusively available to Biograph's Black Tier members that are clinically eligible. Study participants will receive access to Caristo's proprietary CaRi-Heart and CaRi-Plaque technologies to evaluate whether coronary inflammation alongside plaque characterization can detect early heart disease in asymptomatic patients.

CaRi-Heart technology quantifies 'invisible' coronary inflammation on . . .